{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06265727",
            "orgStudyIdInfo": {
                "id": "CRB-701-01"
            },
            "organization": {
                "fullName": "Corbus Pharmaceuticals Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors",
            "officialTitle": "A Phase 1/2 Study to Investigate the Safety, Pharmacokinetics, and Efficacy of CRB-701, an Antibody-drug Conjugate Targeting Nectin-4, in Patients With Advanced Solid Tumors",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-phase-study-to-investigate-crb-in-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-01-16",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-01-27",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-08",
            "studyFirstSubmitQcDate": "2024-02-12",
            "studyFirstPostDateStruct": {
                "date": "2024-02-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Corbus Pharmaceuticals Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to define a safe and effective dose of CRB-701 for participants with solid tumors that are expressing a protein called nectin-4.\n\nThe main questions it aims to answer are:\n\nWhat is the the safe and effective dose of CRB-701 when used alone? What cancers can be treated effectively with CRB-701?\n\nParticipants will be asked to attend clinic and be given a intravenous infusion of CRB-701 on its own. They will have blood tests and other assessments to measure whether CRB-701 will have CT or MRI scans to measure the effect on tumors.",
            "detailedDescription": "This is a three-part open-label, Phase 1/2 clinical trial designed to evaluate the safety, PK, and efficacy of CRB-701 in participants with advanced solid tumors expressing nectin-4.\n\nPart A will include solid tumor types known to express nectin-4. Dose escalation will be guided by the Bayesian optimal interval (BOIN) design to determine the MTD of CRB-701. Four (4) dose groups are pre-determined. Dose escalation/de-escalation decisions are made based on the occurrence of DLT.\n\nPart B will determine the RP2D of CRB-701 by evaluating two dose levels of CRB-701 by using a time-to-event Bayesian optimal Phase 2 (TOP) study design to optimize the dose of CRB-701 in one or more separate cohorts of participants with nectin-4-positive tumors.\n\nDuring Part C, the RP2D dose of CRB-701 will be evaluated in five planned expansion cohorts using Simon's optimal two-stage design."
        },
        "conditionsModule": {
            "conditions": [
                "Solid Tumor, Adult"
            ],
            "keywords": [
                "nectin-4"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "A three part study",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 420,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part A Dose Escalation - CRB-701 Dose Level 1",
                    "type": "EXPERIMENTAL",
                    "description": "CRB-701 Dose level 1, intravenous infusion over 30 mins, Dose schedule 1",
                    "interventionNames": [
                        "Drug: CRB-701"
                    ]
                },
                {
                    "label": "Part A Dose Escalation - CRB-701 Dose Level 2",
                    "type": "EXPERIMENTAL",
                    "description": "CRB-701 Dose Level 2, intravenous infusion over 30 mins, Dose schedule 1",
                    "interventionNames": [
                        "Drug: CRB-701"
                    ]
                },
                {
                    "label": "Part A Dose Escalation - CRB-701 Dose Level 3",
                    "type": "EXPERIMENTAL",
                    "description": "CRB-701 Dose Level 3, intravenous infusion over 30 mins, dose schedule 1",
                    "interventionNames": [
                        "Drug: CRB-701"
                    ]
                },
                {
                    "label": "Part A Dose Escalation - CRB-701 Dose Level 4",
                    "type": "EXPERIMENTAL",
                    "description": "CRB-701 Dose Level 4, intravenous infusion over 30 mins, dose schedule 1",
                    "interventionNames": [
                        "Drug: CRB-701"
                    ]
                },
                {
                    "label": "Part B Dose Optimization: CRB-701 High dose",
                    "type": "EXPERIMENTAL",
                    "description": "Selected high dose of CRB-701, intravenous infusion over 30 mins, dose schedule 1",
                    "interventionNames": [
                        "Drug: CRB-701"
                    ]
                },
                {
                    "label": "Part B Dose Optimization: CRB-701 low dose",
                    "type": "EXPERIMENTAL",
                    "description": "Selected Low dose of CRB-701, intravenous infusion over 30 mins, once every three weeks",
                    "interventionNames": [
                        "Drug: CRB-701"
                    ]
                },
                {
                    "label": "Part C Dose Expansion - Cohort 1",
                    "type": "EXPERIMENTAL",
                    "description": "Recommended Phase 2 dose and schedule of CRB-701, intravenous infusion over 30 mins",
                    "interventionNames": [
                        "Drug: CRB-701"
                    ]
                },
                {
                    "label": "Part C Dose Expansion - Cohort 2",
                    "type": "EXPERIMENTAL",
                    "description": "Recommended Phase 2 dose and schedule of CRB-701, intravenous infusion over 30 mins",
                    "interventionNames": [
                        "Drug: CRB-701"
                    ]
                },
                {
                    "label": "Part C Dose Expansion - Cohort 3",
                    "type": "EXPERIMENTAL",
                    "description": "Recommended Phase 2 dose of CRB-701 and schedule, intravenous infusion over 30 mins",
                    "interventionNames": [
                        "Drug: CRB-701"
                    ]
                },
                {
                    "label": "Part C Dose Expansion - Cohort 4",
                    "type": "EXPERIMENTAL",
                    "description": "Recommended Phase 2 dose of CRB-701 and schedule, intravenous infusion over 30 mins",
                    "interventionNames": [
                        "Drug: CRB-701"
                    ]
                },
                {
                    "label": "Part C Dose Expansion - Cohort 5",
                    "type": "EXPERIMENTAL",
                    "description": "Recommended Phase 2 dose of CRB-701 and schedule, intravenous infusion over 30 mins",
                    "interventionNames": [
                        "Drug: CRB-701"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "CRB-701",
                    "description": "Nectin-4 targeted Antibody Drug Conjugate (ADC)",
                    "armGroupLabels": [
                        "Part A Dose Escalation - CRB-701 Dose Level 1",
                        "Part A Dose Escalation - CRB-701 Dose Level 2",
                        "Part A Dose Escalation - CRB-701 Dose Level 3",
                        "Part A Dose Escalation - CRB-701 Dose Level 4",
                        "Part B Dose Optimization: CRB-701 High dose",
                        "Part B Dose Optimization: CRB-701 low dose",
                        "Part C Dose Expansion - Cohort 1",
                        "Part C Dose Expansion - Cohort 2",
                        "Part C Dose Expansion - Cohort 3",
                        "Part C Dose Expansion - Cohort 4",
                        "Part C Dose Expansion - Cohort 5"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Part A: To confirm the safety and tolerability and determine MTD and PADR for CRB-701",
                    "description": "Occurrence of Dose Limiting Toxicities as defined in the protocol",
                    "timeFrame": "21 days"
                },
                {
                    "measure": "Part B & C : To evaluate efficacy in terms of Disease Control Rate (DCR)",
                    "description": "DCR is the sum of percentage of participants meeting the definition of Complete Response (CR), Partial Response (PR) or Stable Disease (SD) for at least 4 months using RECIST 1.1",
                    "timeFrame": "Up to 6 months"
                },
                {
                    "measure": "Part B & C: To evaluate efficacy in terms of Objective Response Rate (ORR)",
                    "description": "ORR is the percentage of participants that achieve a response (CR + PR) using RECIST 1.1",
                    "timeFrame": "Up to 6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Parts A, B, % C: To characterize the safety profile of CRB-701",
                    "description": "Numbers of treatment emergent adverse events with severity determined using NCI CTCAE v5.0 after single or multiple doses of CRB-701 or single and multiple doses of CRB-701 and an anti-PD-(L)1 therapy",
                    "timeFrame": "Up to 6 months"
                },
                {
                    "measure": "Maximum observed plasma concentration of CRB-701 [total ADC] (Cmax)",
                    "description": "Maximum observed plasma concentration of total ADC after single and multiple doses",
                    "timeFrame": "Approximately 9 weeks"
                },
                {
                    "measure": "Maximum observed plasma concentration of free MMAE (Cmax)",
                    "description": "Maximum observed plasma concentration of free MMAE after single and multiple doses",
                    "timeFrame": "Approximately 9 weeks"
                },
                {
                    "measure": "Maximum observed plasma concentration of Total CRB-701 antibody [Tab] (Cmax)",
                    "description": "Maximum observed plasma concentration of free MMAE after single and multiple doses",
                    "timeFrame": "Approximately 9 weeks"
                },
                {
                    "measure": "Time to reach Cmax of Total CRB-701 [Total ADC] (Tmax)",
                    "description": "The amount of time to reach Cmax after single and multiple dose administration of CRB-701 (Total ADC)",
                    "timeFrame": "Approximately 9 weeks"
                },
                {
                    "measure": "Time to reach Cmax of free MMAE (Tmax)",
                    "description": "The amount of time to reach Cmax after single and multiple dose administration of free MMAE",
                    "timeFrame": "Approximately 9 weeks"
                },
                {
                    "measure": "Time to reach Cmax of Total CRB-701 antibody [Tab] (Tmax)",
                    "description": "The amount of time to reach Cmax after single and multiple dose administration of Tab",
                    "timeFrame": "Approximately 9 weeks"
                },
                {
                    "measure": "Time to reach Cmax of Total CRB-701 antibody [Tab] (Cmax)",
                    "description": "Maximum observed plasma concentration of free MMAE after single and multiple doses",
                    "timeFrame": "Approximately 9 weeks"
                },
                {
                    "measure": "Total Area Under the plasma concentration-time curve of Total CRB-701 [total ADC] (AUC)",
                    "description": "Maximum observed plasma concentration of free MMAE after single and multiple doses",
                    "timeFrame": "Approximately 9 weeks"
                },
                {
                    "measure": "Total Area Under the plasma concentration-time curve of free MMAE (AUC)",
                    "description": "Area under the plasma concentration versus time curve after single and multiple dose administration of free MMAE",
                    "timeFrame": "Approximately 9 weeks"
                },
                {
                    "measure": "Total Area Under the plasma concentration-time curve of Total CRB-701 antibody [Tab] (AUC)",
                    "description": "Area under the plasma concentration versus time curve after single and multiple dose administration of Tab",
                    "timeFrame": "Approximately 9 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Confirmed diagnosis of select advanced or metastatic nectin-4 expressing solid tumors that have progressed following at least one line of therapy or have no other standard therapy with proven clinical benefit.\n\nExclusion Criteria:\n\n* Active of uncontrolled CNS metastases\n* History of solid tumors other than the diseases under study\n* History of and/or current cardiovascular events or conditions in the previous 6 months\n* Pre-existing \\>/= Grade 2 neuropathy\n* Hemoglobin A1C (HbA1C) \\>/= 8%, uncontrolled diabetes mellitus or know diabetic neuropathy\n* Active ocular disease at baseline\n* Chronic severe liver disease or live cirrhosis\n* Interstitial lung disease or pneumonitis within 6 months on initiating treatment on study\n* Other significant cormorbidities.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ian Hodgson, PhD",
                    "role": "CONTACT",
                    "phone": "+1 (617) 963-0105",
                    "email": "Clinical@Corbuspharma.com"
                },
                {
                    "name": "Rodney Carter, BSc",
                    "role": "CONTACT",
                    "email": "Clinical@Corbuspharma.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "David Pinato, MD",
                    "affiliation": "Imperial College London",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Ian Hodgson, PhD",
                    "affiliation": "Corbus International Ltd",
                    "role": "STUDY_DIRECTOR"
                },
                {
                    "name": "Ari Rosenberg, MD",
                    "affiliation": "University of Chicago",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "City of Hope Cancer Center",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "Moores Cancer Centre at UC San Diego Health",
                    "status": "NOT_YET_RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92037",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Helen Diller Family Comprehensive Cancer Center - UCSF",
                    "status": "NOT_YET_RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Rocky Mountain Cancer Centres",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80218",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "Yale Cancer Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06510",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Florida Cancer Specialists",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32806",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "University of Chicago",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Hope and Healing Cancer Center",
                    "status": "RECRUITING",
                    "city": "Hinsdale",
                    "state": "Illinois",
                    "zip": "60521",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.80086,
                        "lon": -87.93701
                    }
                },
                {
                    "facility": "Dana-Faber Cancer Institute",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Nebraska Hematology Oncology",
                    "status": "RECRUITING",
                    "city": "Lincoln",
                    "state": "Nebraska",
                    "zip": "68506",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.8,
                        "lon": -96.66696
                    }
                },
                {
                    "facility": "Carolina BioOncology Institute",
                    "status": "RECRUITING",
                    "city": "Huntersville",
                    "state": "North Carolina",
                    "zip": "28078",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.41069,
                        "lon": -80.84285
                    }
                },
                {
                    "facility": "Texas Oncology",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Tyler",
                    "state": "Texas",
                    "zip": "75702",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.35126,
                        "lon": -95.30106
                    }
                },
                {
                    "facility": "Virginia Cancer Specialists",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Barcelona IOB Hospital Quironsalud (NEXT)",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Barcelona",
                    "zip": "08023",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Vall d-Hebron Institut d'Oncologia",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Fundacion Jimenez Diaz (START)",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Madrid",
                    "zip": "28040",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Clinico Universitario de Valencia",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Valencia",
                    "zip": "46010",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Adana Numune Egitim ve Arastirma Hastanesi (Adana City Education and Research Hospital)",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Adana",
                    "zip": "83114",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.00167,
                        "lon": 35.32889
                    }
                },
                {
                    "facility": "Ankara Etlik City Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Ankara",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Ankara University",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Ankara",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Istanbul Medeniyet University",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Istanbul",
                    "zip": "34720",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clincal@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.01384,
                        "lon": 28.94966
                    }
                },
                {
                    "facility": "University of Birmingham NHS Foundation Trust",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Birmingham",
                    "zip": "B15 2TH",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.48142,
                        "lon": -1.89983
                    }
                },
                {
                    "facility": "University of Cambridge NHS Foundation Trust",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Cambridge",
                    "zip": "CB2 0QQ",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.2,
                        "lon": 0.11667
                    }
                },
                {
                    "facility": "Velindre Cancer Centre",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Cardiff",
                    "zip": "CF15 7QZ",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.48,
                        "lon": -3.18
                    }
                },
                {
                    "facility": "Leeds University Hospitals NHS Trust",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Leeds",
                    "zip": "LS9 7LP",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.79648,
                        "lon": -1.54785
                    }
                },
                {
                    "facility": "Guy's and St Thomas' Clinical Research Facility",
                    "status": "NOT_YET_RECRUITING",
                    "city": "London",
                    "zip": "SE1 9RT",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Imperial Experimental Cancer Medicine Centre",
                    "status": "NOT_YET_RECRUITING",
                    "city": "London",
                    "zip": "W12 0NN",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "The Christie Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Manchester",
                    "zip": "M20 4BX",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                },
                {
                    "facility": "University of Southampton",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Southampton",
                    "zip": "SO16 6YD",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.90395,
                        "lon": -1.40428
                    }
                },
                {
                    "facility": "University of Liverpool - Clatterbridge Medical Centre",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Wirral",
                    "zip": "CH63 4JY",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Rodney Carter",
                            "role": "CONTACT",
                            "email": "Clinical@corbuspharma.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.37616,
                        "lon": -3.10501
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}